We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPMA:NYSESound Point Meridian Capital, Inc. 8.00% Series A Preferred Shares Due 2029 Analysis

Data as of 2026-07-08 - not real-time

$25.06

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock trades at $25.06, marginally below its 20‑day SMA (≈$25.05) and 50‑day SMA (≈$25.10), yet the 200‑day SMA (≈$25.12) remains slightly higher, reinforcing a modest bearish bias. RSI sits at 49.8, indicating a neutral momentum zone, while the MACD histogram is positive and the signal line is flagged as bullish, creating a mixed short‑term technical picture. Volume is on a decreasing trend and daily turnover averages under 3,200 shares, suggesting limited liquidity and heightened price sensitivity. The dividend yield of 7.98% is attractive, but the company posted a revenue decline of 33% YoY and a negative profit margin of –1.74%, raising concerns about cash generation. With $60 M of debt against just $5.8 M of cash, the debt‑to‑equity ratio exceeds 30, and ROE is –43.5%, highlighting balance‑sheet strain.
Given the high beta (~1.2), moderate 30‑day volatility (≈4%), and a thin trading base, price swings could be amplified, especially in a sector where regulatory scrutiny and credit‑quality risk in CLO holdings are material. The combination of an unsustainable dividend, weak earnings, and elevated leverage suggests the current price may be overvalued relative to the underlying fundamentals.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical bias with price below key moving averages
  • Decreasing volume and high beta increasing price volatility
  • Negative earnings surprise and widening profit margin deficit

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Attractive dividend yield but questionable sustainability
  • Continued revenue contraction and high leverage
  • Potential for modest price stabilization around support level

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Persistent negative profitability and weak cash conversion
  • Elevated debt load relative to cash and equity base
  • Sector‑specific credit risk in CLO assets and regulatory exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-33.30%
Profit Margin-174.08%
ROE-43.51%
ROA7.40%
Debt/Equity30.20
P/B Ratio2.6
Op. Cash Flow$6.7M
Free Cash Flow$77.3M
Industry P/E17.4

Technical Analysis

TrendBearish
RSI49.8
Support$24.91
Resistance$25.23
MA 20$25.05
MA 50$25.10
MA 200$25.12
MACDBullish
VolumeDecreasing
Fear & Greed Index91.25

Valuation

GradeOvervalued
TypeValue
Dividend Yield7.98%

Risk Assessment

Beta0.04
Volatility3.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.